Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
Patent 12000847 was granted and assigned to Roche Molecular Systems on June, 2024 by the United States Patent and Trademark Office. | 12000847 | June 4, 2024 | |||||||
Patent 11498074 was granted and assigned to Roche Molecular Systems on November, 2022 by the United States Patent and Trademark Office. | 11498074 | November 15, 2022 | |||||||
Patent 10393659 was granted and assigned to Roche Molecular Systems on August, 2019 by the United States Patent and Trademark Office. | 10393659 | August 27, 2019 | |||||||
Patent 8470267 was granted and assigned to Roche Molecular Systems on June, 2013 by the United States Patent and Trademark Office. | 8470267 | June 25, 2013 | |||||||
Patent 11353382 was granted and assigned to Roche Molecular Systems on June, 2022 by the United States Patent and Trademark Office. | 11353382 | June 7, 2022 | |||||||
Patent 11650404 was granted and assigned to Roche Molecular Systems on May, 2023 by the United States Patent and Trademark Office. | 11650404 | May 16, 2023 | |||||||
Patent 10963821 was granted and assigned to Roche Molecular Systems on March, 2021 by the United States Patent and Trademark Office. | 10963821 | March 30, 2021 | |||||||
Patent 11664126 was granted and assigned to Roche Molecular Systems on May, 2023 by the United States Patent and Trademark Office. | 11664126 | May 30, 2023 | |||||||
Patent 10308381 was granted and assigned to Roche Molecular Systems on June, 2019 by the United States Patent and Trademark Office. | 10308381 | June 4, 2019 | |||||||
Patent 7668663 was granted and assigned to Roche Molecular Systems on February, 2010 by the United States Patent and Trademark Office. | 7668663 | February 23, 2010 | |||||||
Patent 11300578 was granted and assigned to Roche Molecular Systems on April, 2022 by the United States Patent and Trademark Office. | 11300578 | April 12, 2022 | |||||||
Patent 11125660 was granted and assigned to Roche Molecular Systems on September, 2021 by the United States Patent and Trademark Office. | 11125660 | September 21, 2021 | |||||||
Patent 9481903 was granted and assigned to Roche Molecular Systems on November, 2016 by the United States Patent and Trademark Office. | 9481903 | November 1, 2016 | |||||||
Patent 9086396 was granted and assigned to Roche Molecular Systems on July, 2015 by the United States Patent and Trademark Office. | 9086396 | July 21, 2015 | |||||||
Patent 7550291 was granted and assigned to Roche Molecular Systems on June, 2009 by the United States Patent and Trademark Office. | 7550291 | June 23, 2009 | |||||||
Patent 9005551 was granted and assigned to Roche Molecular Systems on April, 2015 by the United States Patent and Trademark Office. | 9005551 | April 14, 2015 | |||||||
Patent 9708599 was granted and assigned to Roche Molecular Systems on July, 2017 by the United States Patent and Trademark Office. | 9708599 | July 18, 2017 | |||||||
Patent 10443050 was granted and assigned to Roche Molecular Systems on October, 2019 by the United States Patent and Trademark Office. | 10443050 | October 15, 2019 | |||||||
Patent 8927209 was granted and assigned to Roche Molecular Systems on January, 2015 by the United States Patent and Trademark Office. | 8927209 | January 6, 2015 | |||||||
Patent 11385170 was granted and assigned to Roche Molecular Systems on July, 2022 by the United States Patent and Trademark Office. | 11385170 | July 12, 2022 | |||||||
Patent 8219324 was granted and assigned to Roche Molecular Systems on July, 2012 by the United States Patent and Trademark Office. | 8219324 | July 10, 2012 | |||||||
Patent 7413855 was granted and assigned to Roche Molecular Systems on August, 2008 by the United States Patent and Trademark Office. | 7413855 | August 19, 2008 | |||||||
Patent 11462325 was granted and assigned to Roche Molecular Systems on October, 2022 by the United States Patent and Trademark Office. | 11462325 | October 4, 2022 | |||||||
Patent 7906767 was granted and assigned to Roche Molecular Systems on March, 2011 by the United States Patent and Trademark Office. | 7906767 | March 15, 2011 | |||||||
Patent 10216895 was granted and assigned to Roche Molecular Systems on February, 2019 by the United States Patent and Trademark Office. | 10216895 | February 26, 2019 |